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In recent years malaria treatment pol-
icies have shifted in most African countries
to artemisinin-based combination thera-
pies (ACT), which are highly effective but
also much more expensive than previous
regimens [1]. In order to avoid over-
prescription of ACT, new guidelines from
the World Health Organization recom-
mend that a laboratory test should be
performed before treating [2]. The wide-
spread introduction of rapid diagnostic
tests (RDTs) for malaria allows diagnosis
to be made even in health settings lacking
any laboratory facility. Since RDTs gen-
erally cost less than a full course of ACT,
their introduction should not only improve
malaria management but should also limit
malaria treatment costs.
However, recent research has shown
that clinicians are reluctant to refrain from
treating for malaria after a negative test
[3,4]. Clinicians’ adherence to a test-based
strategy is a key factor in determining
whether the strategy is effective at improv-
ing management and curtailing costs [5,6].
If the result of a test is not going to
influence management, then doing the test
is a waste of money [6]. Moreover, RDT-
based policy is usually restricted to adults
and older children, while for under-fives
presumptive malaria treatment of all fevers
is still recommended [2]. This leads to the
paradox that the improved diagnostic
techniques are of no utility for the group
at highest mortality risk.
Test-Based Malaria
Management in Children
PLoS Medicine recently published a
provocative debate on whether or not
presumptive treatment in under-fives
should be abandoned. Vale ´rie D’Acre-
mont and colleagues argued that it is high
time to move to laboratory-confirmed
(usually RDT-based) diagnosis for younger
children [7]. They noted that malaria
incidence is declining in many countries,
and so is the probability that an African
child with fever has malaria—thus treating
all fevers in children as malaria would lead
clinicians to miss other, potentially fatal,
causes. Mike English and colleagues re-
plied that the reported sub-optimal sensi-
tivity of RDTs in routine use means that
use of RDTs risks missing true malaria
cases [8]. Moreover, they argued, the poor
adherence of health professionals to a test-
based management strategy might not be
easy to solve just by training.
The divided opinion on this topic
reflects a lack of evidence. There is not
yet enough evidence for the safety of a test-
based strategy for young children, and
there is no evidence that satisfactory
adherence to a test-based management
strategy can be achieved by training.
Operational research is needed to fill in
these evidence gaps [6]. A new study in
this issue of PLoS Medicine, by Anders
Bjorkman and colleagues, addresses these
research priorities [9].
A New Study on Malaria
Management Based on RDTs
Bjorkman and colleagues conducted a
cross-over clinical trial of symptom-based
clinical diagnosis (CD) versus CD plus
RDT in four primary health care facilities
in Zanzibar. Patients of all ages with
reported fever lasting 48 hours were
eligible, and they were allocated on
alternate weeks to CD alone or CD+RDT.
Follow-up was 14 days, and ACT was
prescribed to patients diagnosed with
malaria in both groups. Malaria manage-
ment was provided by registered nurses,
all of whom had been trained in malaria
case management. The RDT was a
histidine-rich protein 2–based test called
Paracheck.
The use of RDT had a major impact on
clinical decisions. In children, the pre-
scription rate of antimalarial treatments in
the CD+RDT group was half that ob-
served in the CD group (42% versus 84%
and 44% versus 86% for children under
five years and five to 15 years, respective-
ly). In adults, the difference was even more
striking (16% versus 87%). Although the
authors do not give details about specific
decisions taken according to RDT results,
this difference suggests that the compli-
ance was very high, as most RDT-negative
patients were not treated for malaria. The
prescription rate of antibiotics was higher
in the CD+RDT group than in the CD
group, suggesting that negative malaria
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Linked Research Article
This Perspective discusses the fol-
lowing new study published in PLoS
Medicine:
Msellem MI, Ma ˚rtensson A, Rotllant
G, Bhattarai A, Stro ¨mberg J, et al.
(2009) Influence of rapid malaria
diagnostic tests on treatment and
health outcome in fever patients,
Zanzibar—A crossover validation
study. PLoS Med 6(5): e1000070.
doi:10.1371/journal.pmed.1000070
10.1371/journal.pmed.1000070
Anders Bjorkman and colleagues
report results from a crossover trial
evaluating rapid diagnostic testing
for malaria diagnosis in Zanzibar.
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treat alternative causes of fever.
No death was recorded in either group
at 14 days of follow-up. The authors do
not specify if they observed a difference in
frequency of severe complications and/or
of referral to a higher level of care;
however, the patients in the CD+RDT
group were less likely to re-attend the
clinic during the follow-up period.
Implications for Malaria
Management Policies
Are these results generalisable—do they
suggest that a test-based policy should be
recommended even for young children?
We will briefly examine the main issues:
adherence, safety, and cost.
For the purpose of this study, nurses
were trained for one day only. In two of
the four health centres, RDTs were
introduced for the first time. The excellent
adherence to test-based management seen
in the trial is surprising, and contrasts with
previous studies [3,4,10], as well as with
our recent findings in Burkina Faso [11].
In our study, even after a three-day
training, adherence remained very poor:
80% of RDT-negative febrile patients
were treated for malaria in the dry season,
and 85% in the rainy season [11]. There
are many possible reasons to explain the
striking difference between Bjorkman and
colleagues’ results and those seen in other
studies (including our study). We believe
that a major reason for the difference was
that in Bjorkman and colleagues’ study,
the research assistants were also the
prescribers, having to record their own
prescribing behaviour, which may have
influenced their decisions. The very en-
couraging adherence rates in this new
study should be corroborated by further
research on teaching and supervision
strategies aimed at achieving satisfactory
compliance in real-life situations.
As far as safety is concerned, Bjorkman
and colleagues’ study indicates that the
RDT-based management strategy is safe
for both adults and children. The study
found no severe malaria case after a
missed malaria treatment following a false
negative result. Moreover, the lower rate
of re-attendance in the CD+RDT group
suggests a better clinical outcome. Never-
theless, definitive evidence on safety can
only be found by a study that is adequately
powered to detect differences in severe
clinical outcomes, including deaths, and/
or by pooling results obtained in different
study settings [11].
Are RDTs cost-effective? Bjorkman and
colleagues found that overall cost was the
same with CD as with CD+RDT. How-
ever, the test-based strategy was associated
with cost savings in adults (overall cost
US$2.74 with CD+RDT versus US$3.02
with CD alone), due to the much lower
proportion of malaria treatment in this
group. Since Bjorkman and colleagues
conducted their trial, malaria incidence
in Zanzibar has further declined [12], and
the test-based strategy would probably
become even more cost-effective should
this decline persist.
Conclusion
This new study brings additional argu-
ments, albeit no definite evidence, in
favour of extending an RDT-based ma-
laria management strategy to young chil-
dren, in a situation of moderate- to low-
intensity malaria transmission. This strat-
egy would, however, be justified only if
adherence to test results were optimal,
which remains to be proved in real-life
situations. More research is also needed in
settings where malaria transmission inten-
sity is higher and/or seasonal variation is
greater.
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